Back to search results

Geriatric Care for Older Adults with Breast Cancer

This study is for older adults (65 years or older) with stage I-III breast cancer who have finished their curative treatment. It explores whether a special geriatric care program can improve your overall health and quality of life. This program involves a complete geriatric assessment (a thorough check of your physical, mental, and emotional health), education about survivorship care, wearing an activity tracker, and receiving support based on your assessment. Researchers will measure your quality of life using questionnaires like the Functional Assessment of Cancer Therapy-Breast (FACT-B) over about one year to see if the intervention helps. The study aims to enroll 15 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 15 participants.
What's involved
Participants will undergo comprehensive geriatric assessments, receive survivorship care education, wear an activity tracking device, and receive support based on their assessments. These activities will occur over an average of one year.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed through study completion, which is an average of one year, with assessments at 6 and 12 months post-chemotherapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05928325

Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment

Active, Not Recruiting
NAAges 65+InterventionalSupportive care
M.D. Anderson Cancer Center
~15 participants
Updated 2026-05-05 on ClinicalTrials.gov
What's tested:Comprehensive Geriatric AssessmentHealth EducationMedical Device Usage and EvaluationSupportive Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaires
Measured over through study completion; an average of 1 year.

Conditions

Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8

Explore related trials

Breast Carcinoma

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Meghan Karuturi, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

\>= 65-years-old
Histologically confirmed Stage I, II or III breast cancer (if the patient has had more than one breast cancer, the most recent diagnosis)
Within 8 (+/- 14 days) weeks of completing a chemotherapy regimen for breast cancer either as standard-of-care or on a study (can be receiving concomitant radiation, HER-2 targeted agents and/or endocrine therapy)
English or Spanish speaking
Able to provide written, informed consent
Willing and able to meet all study requirement
CAREGIVER ELIGIBILITY: \>= 18-years-old
CAREGIVER ELIGIBILITY: Ability to complete required study procedures

Exclusion

The presence of significant medical conditions that in the physician's (either the patient's primary oncologist of the study principal investigator) judgement preclude participation in the exercise intervention

What this trial measures

  • Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnairesthrough study completion; an average of 1 year.

    The FACT-G is a 27-item instrument that uses a 5-point Likert-type scale (0=not at all, 1=a little bit, 2=somewhat, 3=quite a bit, 4=very much).